July 28, 1998 |
BioSource International in Camarillo announced sales of $5.3 million and net income of $801,314 or 10 cents per diluted share, for the second quarter ended June 30. A year earlier, sales were $5 million and net income was $772,435 or 9 cents per diluted share. The increase in quarterly net income compared to a year ago was achieved while BioSource increased its investment in research and development by $154,250 or 29%, company officials said.
May 5, 1998 |
BioSource International in Camarillo announced first-quarter sales of $5.3 million and net income of $816,169 or 10 cents per diluted share. A year earlier, BioSource reported revenues of $5.4 million and net income of $862,155 or 10 cents per diluted share. While sales revenue for the 1998 first quarter was the second highest in the company's history, net income was affected by a pretax charge of $158,000 or 2 cents per diluted share for moving expenses.
December 30, 1997 |
BioSource International in Camarillo has extended the company's common-stock repurchase program and authorized the purchase of up to 1 million shares by Dec. 23, 1998. BioSource's board of directors voted to extend the program's duration and expand the number of shares that may be purchased. Because of the recent price range of the stock, the board decided to more aggressively buy shares.
November 11, 1997 |
Third-quarter results for BioSource International in Camarillo were the second best in the company's history, with revenues of $5.18 million and net income of $855,401--or 10 cents per share--for the three months ending Sept. 30. The figures were comparable to the three months that ended Sept. 30, 1996, when BioSource reported revenues of $5.04 million and net income of $806,380, or 10 cents per share.
November 4, 1997
Biosource International Inc., the Camarillo-based manufacturer of immunological reagents and test kits used in biomedical research, reported a net income of $855,400 for its third quarter, up 6% from $806,400 a year earlier. Sales for the three months that ended Sept. 30 were $5.2 million, up 4% from $5 million in 1996. For the nine months, earnings rose to $2.5 million, up 32% from $1.9 million a year ago, while revenue rose to $15.7 million, up 45% from $10.8 million.
December 3, 1996 |
BioSource International in Camarillo has hired a new vice president, who will be responsible for the company's immunology product lines. Kevin J. Reagan, PhD, will join the company early next month, BioSource officials said. For the past five years, Reagan has worked for Specialty Laboratories of Santa Monica, most recently as vice president of laboratory operations. BioSource also announced that Dr. Thomas J. Moss has agreed to serve on the company's scientific advisory board.